JP Morgan Initiates Sangamo BioSciences With Overweight

Analysts at JP Morgan initiated coverage on shares of Sangamo BioSciences

with a Overweight rating. The target price for Sangamo BioSciences is set to $22. Sangamo BioSciences shares have surged 19.04% over the past 52 weeks, while the S&P 500 index has gained 12.93% in the same period. Sangamo BioSciences' shares dropped 5.19% to close at $11.88 yesterday.